
Keywords: Surveillance; Prognostic Factor; Biomarker; Tumor; BD-IPMN; branch-duct intraductal papillary mucinous neoplasm; CI; confidence interval; CT; computed tomography; MRCP; magnetic resonance cholangiopancreatography; MRI; magnetic resonance imaging; OR; odds